McMaster iGEM x Shad at Mac Design Case Competition 2026: Expanding Blood Donor Eligibility with Synthetic Biology
Undergraduate Research in Natural and Clinical Science and Technology Journal · 31.05.2026 · A1-A4
DOI: 10.26685/urncst.1125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Undergraduate Research in Natural and Clinical Science and Technology Journal, online erschienen am 31.05.2026. Verfasst von Shreya Subramanian und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Approximately 7.1 million people are deterred from donating blood due to certain exclusion criteria placed by the Canadian Blood Services to allow for safe transfusion. Participants were required to devise synthetic biology solutions to widen the blood inclusion criteria set by the Canadian Blood Services to allow more individuals to donate. The following are abstracts from the case competition hosted by Shad@Mac and iGEM McMaster.
Zitieren
APA
Subramanian, S., Ren, J., Puusaari, M., Zhao, A., Bui, A., & Thavaranjan, K. (2026). McMaster iGEM x Shad at Mac Design Case Competition 2026: Expanding Blood Donor Eligibility with Synthetic Biology. Undergraduate Research in Natural and Clinical Science and Technology Journal, A1-A4. https://doi.org/10.26685/urncst.1125
Vancouver
Subramanian S, Ren J, Puusaari M, Zhao A, Bui A, Thavaranjan K. McMaster iGEM x Shad at Mac Design Case Competition 2026: Expanding Blood Donor Eligibility with Synthetic Biology. Undergraduate Research in Natural and Clinical Science and Technology Journal. 2026:A1-A4. doi:10.26685/urncst.1125
BibTeX
@article{Subramanian2026,
author = {Subramanian, Shreya and Ren, Jiawen and Puusaari, Morgan and Zhao, Adelina and Bui, Anh and Thavaranjan, Kishaani},
title = {McMaster iGEM x Shad at Mac Design Case Competition 2026: Expanding Blood Donor Eligibility with Synthetic Biology},
journal = {Undergraduate Research in Natural and Clinical Science and Technology Journal},
year = {2026},
pages = {A1--A4},
doi = {10.26685/urncst.1125}
}
EUVIMED